Caregen Co., Ltd.
股价图表
关键指标
- 市值
- ₩1.78T
- 市盈率
- 80.7x
- 市净率
- 7.63x
- 净资产收益率
- 9.2%
Caregen Co., Ltd.
暂无公司简介。
- CEO
- 정용지
- 员工人数
- 0
暂无公司简介。
| 财年 | 营业收入 | 营业利润 | 净利润 | 营业利润率 |
|---|---|---|---|---|
| 2025 | ₩72.81B | ₩20.40B | ₩20.10B | 28.0% |
| 2024 | ₩82.59B | ₩34.25B | ₩32.31B | 41.5% |
| 2023 | ₩79.21B | ₩40.38B | ₩39.93B | 51.0% |
| 2022 | ₩69.10B | ₩33.63B | ₩27.22B | 48.7% |
Ngen Bio, HLB Genex, Caregen, Korea Biotech, BC World Pharma, Chaperon, Jin Systems, Aptabio, Macrogen, Hyundai Bio, Inbiogen, Dreamtech, Pharmicell, Rigakem Bio, Inventis Lab, Biosmart, Genomic Tree, SV Investment...
pinpointnews2026年10月29日
On the other hand, Caregen, Celltrion Pharmaceutical, Genexine, HLB Therapeutics, HK Inno.N, and Hanmi Pharmaceutical are showing weakness. Inventis Lab, Lapaas, HLB Pharmaceuticals, Curatis, and Synergy Innovation, which are developing long-acting drug delivery technologies, are also under selling pressure. Recent stock prices...
pinpointnews2026年10月29日
Caregen, a peptide-based business, and Novaex, a health supplement manufacturer, are also showing weakness. Gradient and Seohung have recorded declines as well. Raw material and ingredient-related companies Jongkundang Bio and S&D, along with the bio business DXVX, are also...
数据来源: 财务数据以 DART 公告原文为准。价格与分析师一致预期来自持牌数据提供商。 最新年度业绩:2025 财年,截至 。 不构成投资建议。 DART 公告 · 数据如何采集 · 报告错误
In the KOSDAQ, major stocks that rose include Alteogen (1.92%), EcoPro (10.21%), EcoPro BM (7.20%), Rainbow Robotics (7.38%), ABL Bio (8.07%), Kolon TissueGene (6.77%), Samchundang Pharm (2.93%), HLB (2.76%), and Caregen (2.52%).
smartbizn2026年10月19日
Among large-cap stocks, Alteogen (0.58%), ABL Bio (0.76%), Kolon TissueGene (0.12%), Caregen (1.97%), Samchundang Pharm (1.24%), and HLB (-1.16%) saw gains. Ecopro (-1.99%), Ecopro BM (-2.40%), Rainbow Robotics (-0.54)...
smartbizn2026年10月7日